Skin Safety Study to Evaluate the Irritation Potential in Healthy Volunteers

Summary

This is a single center, randomized, controlled, within-subject comparison, multiple dose study to determine the irritation potential of M518101 on normal skin under occlusive patch condition. The study drug will be applied for 21 days under occlusive patch condition. The irritation potential of M518101 will be compared with positive, negative control and M518101 vehicle. The study duration is 21days and there will be at least 23 visits to study center including screening visit.

Timeline

Start

2014-09

Primary completion

2014-10

Completion

2015-03

Drugs

Indications

No indication recorded.